These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29528967)

  • 1. Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop.
    Rickels MR; Stock PG; de Koning EJP; Piemonti L; Pratschke J; Alejandro R; Bellin MD; Berney T; Choudhary P; Johnson PR; Kandaswamy R; Kay TWH; Keymeulen B; Kudva YC; Latres E; Langer RM; Lehmann R; Ludwig B; Markmann JF; Marinac M; Odorico JS; Pattou F; Senior PA; Shaw JAM; Vantyghem MC; White S
    Transplantation; 2018 Sep; 102(9):1479-1486. PubMed ID: 29528967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop.
    Rickels MR; Stock PG; de Koning EJP; Piemonti L; Pratschke J; Alejandro R; Bellin MD; Berney T; Choudhary P; Johnson PR; Kandaswamy R; Kay TWH; Keymeulen B; Kudva YC; Latres E; Langer RM; Lehmann R; Ludwig B; Markmann JF; Marinac M; Odorico JS; Pattou F; Senior PA; Shaw JAM; Vantyghem MC; White S
    Transpl Int; 2018 Apr; 31(4):343-352. PubMed ID: 29453879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the Igls Criteria for Defining Functional Outcomes of β-cell Replacement Therapy: IPITA Symposium Report.
    Landstra CP; Andres A; Chetboun M; Conte C; Kelly Y; Berney T; de Koning EJP; Piemonti L; Stock PG; Pattou F; Vantyghem MC; Bellin MD; Rickels MR
    J Clin Endocrinol Metab; 2021 Sep; 106(10):3049-3059. PubMed ID: 34061967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining outcomes for beta cell replacement therapy: a work in progress.
    Piemonti L; de Koning EJP; Berney T; Odorico JS; Markmann JF; Stock PG; Rickels MR
    Diabetologia; 2018 Jun; 61(6):1273-1276. PubMed ID: 29511779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-score greater than 3).
    Vantyghem MC; Raverdy V; Balavoine AS; Defrance F; Caiazzo R; Arnalsteen L; Gmyr V; Hazzan M; Noël C; Kerr-Conte J; Pattou F
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2078-83. PubMed ID: 22996144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
    Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
    Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.
    Bartlett ST; Markmann JF; Johnson P; Korsgren O; Hering BJ; Scharp D; Kay TW; Bromberg J; Odorico JS; Weir GC; Bridges N; Kandaswamy R; Stock P; Friend P; Gotoh M; Cooper DK; Park CG; OʼConnell P; Stabler C; Matsumoto S; Ludwig B; Choudhary P; Kovatchev B; Rickels MR; Sykes M; Wood K; Kraemer K; Hwa A; Stanley E; Ricordi C; Zimmerman M; Greenstein J; Montanya E; Otonkoski T
    Transplantation; 2016 Feb; 100 Suppl 2(Suppl 2):S1-44. PubMed ID: 26840096
    [No Abstract]   [Full Text] [Related]  

  • 8. Benefits of Islet Transplantation as an Alternative to Pancreas Transplantation: Retrospective Study of More Than 10 Ten Years of Experience in a Single Center.
    Voglová B; Zahradnická M; Girman P; Kríž J; Berková Z; Koblas T; Vávrová E; Németová L; Kosinová L; Habart D; Fábryová E; Dovolilová E; Leontovyc I; Neškudla T; Peregrin J; Kovác J; Lipár K; Kocík M; Marada T; Svoboda J; Saudek F
    Rev Diabet Stud; 2017; 14(1):10-21. PubMed ID: 28632818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful islet transplantation: continued insulin reserve provides long-term glycemic control.
    Ryan EA; Lakey JR; Paty BW; Imes S; Korbutt GS; Kneteman NM; Bigam D; Rajotte RV; Shapiro AM
    Diabetes; 2002 Jul; 51(7):2148-57. PubMed ID: 12086945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.
    Chetboun M; Drumez E; Ballou C; Maanaoui M; Payne E; Barton F; Kerr-Conte J; Vantyghem MC; Piemonti L; Rickels MR; Labreuche J; Pattou F;
    Lancet Diabetes Endocrinol; 2023 Jun; 11(6):391-401. PubMed ID: 37105208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary graft function, metabolic control, and graft survival after islet transplantation.
    Vantyghem MC; Kerr-Conte J; Arnalsteen L; Sergent G; Defrance F; Gmyr V; Declerck N; Raverdy V; Vandewalle B; Pigny P; Noel C; Pattou F
    Diabetes Care; 2009 Aug; 32(8):1473-8. PubMed ID: 19638525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR).
    Baidal DA; Ballou CM; Rickels MR; Berney T; Pattou F; Payne EH; Barton FB; Alejandro R;
    Diabetes Care; 2023 Apr; 46(4):697-703. PubMed ID: 36657975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs.
    Luo M; Kong X; Wang H; Zhai X; Cai T; Ding B; Hu Y; Jing T; Su X; Li H; Ma J
    J Diabetes Res; 2020; 2020():6666403. PubMed ID: 33299890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term function (6 years) of islet allografts in type 1 diabetes.
    Alejandro R; Lehmann R; Ricordi C; Kenyon NS; Angelico MC; Burke G; Esquenazi V; Nery J; Betancourt AE; Kong SS; Miller J; Mintz DH
    Diabetes; 1997 Dec; 46(12):1983-9. PubMed ID: 9392484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islets isolated from donors with elevated HbA1c can be successfully transplanted.
    Koh A; Kin T; Imes S; Shapiro AM; Senior P
    Transplantation; 2008 Dec; 86(11):1622-4. PubMed ID: 19077899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 6: patient selection for pilot clinical trials of islet xenotransplantation.
    Hering BJ; O'Connell PJ
    Xenotransplantation; 2016; 23(1):60-76. PubMed ID: 26918540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International trial of the Edmonton protocol for islet transplantation.
    Shapiro AM; Ricordi C; Hering BJ; Auchincloss H; Lindblad R; Robertson RP; Secchi A; Brendel MD; Berney T; Brennan DC; Cagliero E; Alejandro R; Ryan EA; DiMercurio B; Morel P; Polonsky KS; Reems JA; Bretzel RG; Bertuzzi F; Froud T; Kandaswamy R; Sutherland DE; Eisenbarth G; Segal M; Preiksaitis J; Korbutt GS; Barton FB; Viviano L; Seyfert-Margolis V; Bluestone J; Lakey JR
    N Engl J Med; 2006 Sep; 355(13):1318-30. PubMed ID: 17005949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative impact on islet isolation and transplant outcome of the preservation solutions Institut Georges Lopez-1, University of Wisconsin, and Celsior.
    Niclauss N; Wojtusciszyn A; Morel P; Demuylder-Mischler S; Brault C; Parnaud G; Ris F; Bosco D; Badet L; Benhamou PY; Berney T
    Transplantation; 2012 Apr; 93(7):703-8. PubMed ID: 22343333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet transplantation as safe and efficacious method to restore glycemic control and to avoid severe hypoglycemia after donor organ failure in pancreas transplantation.
    Gerber PA; Hochuli M; Benediktsdottir BD; Zuellig RA; Tschopp O; Glenck M; de Rougemont O; Oberkofler C; Spinas GA; Lehmann R
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29140547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation.
    Brooks AM; Oram R; Home P; Steen N; Shaw JA
    Diabetes Care; 2015 Jan; 38(1):105-12. PubMed ID: 25422169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.